SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-16-000425
Filing Date
2016-05-23
Accepted
2016-05-23 16:45:27
Documents
26
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 f33116form10qvedgar7.htm 10-Q 432974
2 exhibit3101.htm EX-31 8538
3 exhibit3102.htm EX-31 9099
4 exhibit3201.htm EX-32 4242
  Complete submission text file 0001551163-16-000425.txt   1030917

Data Files

Seq Description Document Type Size
5 sgbi-20160331.xml EX-101.INS 61013
6 sgbi-20160331.xsd EX-101.SCH 7540
7 sgbi-20160331_cal.xml EX-101.CAL 16784
8 sgbi-20160331_def.xml EX-101.DEF 5280
9 sgbi-20160331_lab.xml EX-101.LAB 75067
10 sgbi-20160331_pre.xml EX-101.PRE 57132
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 161669627
SIC: 2834 Pharmaceutical Preparations